Therapeutic targeting of ERBB2 in breast cancer: understanding resistance in the laboratory and combating it in the clinic
Crossref DOI link: https://doi.org/10.1007/s00109-014-1169-7
Published Online: 2014-05-28
Published Print: 2014-07
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Fabi, Alessandra
Mottolese, Marcella
Segatto, Oreste
Text and Data Mining valid from 2014-05-28